SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-16-078067
Filing Date
2016-08-29
Accepted
2016-08-29 16:31:31
Documents
6
Period of Report
2016-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ONCOCYTE CORPORATION 8-K 8-29-2016 form8k.htm 8-K 28189
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 122440
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 301378
4 EXHIBIT 10.2 ex10_2.htm EX-10.2 302335
5 EXHIBIT 99.1 ex99_1.htm EX-99.1 10708
6 image00002.jpg GRAPHIC 3879
  Complete submission text file 0001140361-16-078067.txt   771755
Mailing Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502 510-521-3390
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 161858180
SIC: 2835 In Vitro & In Vivo Diagnostic Substances